Literature DB >> 9500754

Purification, characterization, and partial sequencing of two new allergens of Olea europaea.

L Boluda1, C Alonso, E Fernández-Caldas.   

Abstract

BACKGROUND: The inhalation of olive (Olea europaea) pollen is an important cause of allergic respiratory diseases in southern Europe and California.
OBJECTIVE: The aims of this study were to characterize the allergenic composition of O. europaea pollen collected in California and to purify two important allergens.
METHODS: One hundred grams of O. europaea pollen was extracted dialyzed in 10 kd cut-off membranes and lyophilized. Allergen characterization was done by sodium dodecylsulfate-polyacrylamide gel electrophoresis and immunoblotting. Two allergens were isolated by gel filtration, ion exchange, and hydrophobic interaction chromatography and sequenced.
RESULTS: Ole e 4 has an apparent molecular weight, under reducing conditions, of 32 kd and pIs between 4.65 and 5.1. The N-terminal was blocked and the analysis of the amino acid sequence of two internal regions revealed no homology with other known proteins. Ole e 5 has a molecular weight of 16 kd and pIs between 5.1 and 6.5. The amino acid sequence of the N-terminal showed a high degree of homology with superoxide dismutase of several plant species. Ole e 4 and Ole e 5 had an IgE binding frequency by immunoblot of 80% and 35%, respectively.
CONCLUSIONS: Olive pollen extracts have a heterogeneous composition, with several important allergens. One of these allergens showed a high degree of homology with a superoxide dismutase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500754     DOI: 10.1016/S0091-6749(98)70385-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  1 in total

1.  Identification of novel superoxide dismutase isoenzymes in the olive (Olea europaea L.) pollen.

Authors:  Adoración Zafra; Antonio Jesús Castro; Juan de Dios Alché
Journal:  BMC Plant Biol       Date:  2018-06-08       Impact factor: 4.215

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.